Search
for
Sort by
Research 121–150 of 338
- Abstracts from the 2024 WDS Forum - virtual option
- Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Editor's Highlights — September 2024
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Multi-omics revealed that the postbiotic of hawthorn-probiotic alleviated constipation caused by loperamide in elderly mice
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Farmácia da Boa Hora, Porto e nos Serviços Farmacêuticos do Hospital Lusíadas, Porto
- 573 Discovery of JW0061, a novel GFRA1 agonist, as a hair regeneration stimulant via WNT signaling activation in dermal papilla cells
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Ann Robinson’s research reviews —12 May 2022
- Poster Abstracts
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Stem Cells and the Niche: A Dynamic Duo
- Epigenetic control of adult stem cell function
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Polycystic Ovarian Syndrome
- How to diagnose a lipodystrophy syndrome
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- <i>Acorus calamus</i>: a bio-reserve of medicinal values